| Affiliation: | 1. School of Pathology and Laboratory Medicine, University of Western Australia, Australia;2. Communicable Disease Control Directorate, Western Australia Department of Health, Australia;1. 454 Life Sciences, A Roche Company, Branford, CT, USA;2. National Institute for Infectious Diseases “L. Spallanzani, Rome, Italy;3. Janssen Infectious Diseases – Diagnostics bvba, Beerse, Belgium;4. Centre Jean Perrin/Clermont University, Clermont-Ferrand, France;5. GeT-PlaGe, INRA 0444 LGC, Castanet-Tolosan, France;6. Red Cross Transfusion Service of Upper Austria, Linz, Austria;7. INSERM U1043 and Virology Laboratory, CHU Toulouse, Toulouse, France;8. Medical University of Graz, Graz, Austria;9. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland;10. Functional Genomics Center Zurich, University of Zurich, ETH Zurich, Zurich, Switzerland;11. Robert Koch-Institute, Berlin, Germany;12. IrsiCaixa AIDS Research Institute, Badalona, Spain;13. CHU Bordeaux and UMR 5234, MFP Univ. Bordeaux, Bordeaux, France;14. TIA-National Genomics Platform, Durban, South Africa;15. Roche Applied Science, Penzberg, Germany;p. Institute of Immunology and Genetics, Kaiserslautern, Germany;1. Bioanalytical services, Dynakin, S.L, Bizkaia Technology Park, 48160 Derio, Bizkaia, Spain;2. Noorik Biopharmaceuticals, Lange Gasse 15, 4052 Basel, Switzerland |
